In 2023, the share of Canada's scientific publications within the top 10% most cited in endocrinology was 9.07%. The forecast from 2024 to 2028 shows a gradual decline from 9.01% to 8.77%. The year-on-year percentage decreases are consistent, averaging a compound annual growth rate (CAGR) of approximately -0.7% over the projected period, indicating a slight decrease in Canada's influence in high-impact endocrinology research relative to global peers.
Future trends to watch for:
- Opportunities to enhance Canada's visibility in high-impact endocrinology research through increased collaboration and innovative research approaches.
- The influence of global research funding and policy changes, which could affect Canada's share of top-cited publications.
- Trends in international research partnerships and their impacts on Canada's scholarly output.